InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-9.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Duarte Ira, Chief Financial Officer. Insider active across 3 companies, notably Heron Therapeutics, INC.. Cumulatively, 16 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €70k. History available since 22 June 2023. The latest transaction was disclosed on 31 December 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations16 total
12,500 sharesCommon StockSEC:0001193125-26-273552:0
3,555 sharesCommon StockSEC:0001193125-26-273552:1
11,695 sharesCommon StockSEC:0000950170-25-102158
11,695 sharesCommon StockSEC:0000950170-25-102158:0
3,874 sharesCommon StockSEC:0000950170-25-097498:0
11,694 sharesCommon StockSEC:0000950170-25-063063:0
3,875 sharesCommon StockSEC:0000950170-25-056492:0
3,874 sharesCommon StockSEC:0000950170-25-007557:0
71,704 shares@ US$0.65100.0% of flowCommon SharesSEC:0001415889-25-000381:0
3,874 sharesCommon StockSEC:0000950170-24-115927:0
3,875 sharesCommon StockSEC:0000950170-24-085089:0
163,334 shares0Common SharesSEC:0001415889-24-017689:0
12,500 sharesCommon StockSEC:0000950170-24-074168:0
3,874 sharesCommon StockSEC:0000950170-24-046134:0
85,000 shares@ US$0.8894100.0% of flowCommon StockSEC:0001209191-23-055663:0
Ideal exit: 12 Aug 2024 (T+270)
132,647 shares0Common StockSEC:0001209191-23-039628:0
16 of 16 declarations
About Duarte Ira
Ira Duarte is the Chief Financial Officer and Executive Vice President of HERON THERAPEUTICS, INC. In this role, he oversees the financial management of the company, including budgeting and financial reporting. His expertise is essential in ensuring the financial health of Heron Therapeutics and supporting its growth. With a strong background in finance, he contributes to strategic decision-making.
